Moreover, Kuo Lin et al. confirmed that the downregulation of SIRT1 by a specific inhibitor causes an anti-breast cancer cell effect by blocking the activity of the Bcl-2 protein, which is a pro-survival protein which protects cells from apoptosis [44]. This evidence concerns the gene BCL2 and breast carcinoma.